Loading clinical trials...
Loading clinical trials...
Minimizing Leukemia Relapse: A Phase I, Dose Escalation Study of Decitabine in High Risk Pediatric Leukemia Post Allogeneic Transplant
Conditions
Interventions
Decitabine
Locations
1
United States
UF Health Shands Hospital
Gainesville, Florida, United States
Start Date
October 1, 2014
Primary Completion Date
October 1, 2016
Completion Date
September 18, 2018
Last Updated
October 15, 2018
NCT01186328
NCT00539656
NCT00179764
NCT01761682
NCT03331211
NCT00100152
Lead Sponsor
University of Florida
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions